Impending shortage of cytotechnologists.

Abstract

At the very time when the Administration is pressing for an increase of $100 million in Federal expenditures for the conquest of cancer, a shortage of cytotechnologists, who are valuable in research as well as control, may occur. When Congress passed the Partnership for Health Act and section 314E became effective in June 1970, cancer was among the categorical diseases that lost Federal support for control activities. The Cancer Control Program, which was funding 78 training programs in cytotechnology, ended.